Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,511 | 54,690 | 21,315 | 21,199 | 17,069 |
| Marketable Securities | 22,664 | 18,232 | 16,891 | 14,708 | 25,274 |
| Receivables | 6,243 | 9,490 | 2,115 | 4,562 | 5,831 |
| Inventories | 1,612 | 683 | N/A | N/A | 263 |
| Other current assets | 90 | 76 | 75 | 412 | 4,043 |
| TOTAL | $63,794 | $89,343 | $42,121 | $41,978 | $52,858 |
| Non-Current Assets | |||||
| PPE Net | 5,149 | 207 | 306 | 583 | 1,098 |
| Investments And Advances | 47,683 | 41,116 | 2,582 | 1,151 | 15,382 |
| Other Non-Current Assets | 5,733 | 6,208 | 3,857 | 13,727 | 12,870 |
| TOTAL | $58,565 | $47,531 | $6,745 | $15,461 | $29,350 |
| Total Assets | $122,359 | $136,874 | $48,866 | $57,439 | $82,208 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,053 | 8,878 | 8,041 | 5,972 | 3,897 |
| Accrued Expenses | 16,237 | 11,329 | 5,742 | 9,860 | 12,616 |
| TOTAL | $62,257 | $57,293 | $15,256 | $17,224 | $26,299 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 30,000 | 30,000 | 30,000 |
| Deferred Revenues | 2,163 | 7,086 | 1,473 | 1,392 | 9,786 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 4,749 | 4,000 |
| TOTAL | $12,378 | $3,946 | $34,736 | $40,669 | $41,103 |
| Total Liabilities | $74,635 | $61,239 | $49,992 | $57,893 | $67,402 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,630 | 72,320 | 59,385 | 50,928 | 46,038 |
| Common Shares | 734 | 720 | 591 | 509 | 457 |
| Retained earnings | -510,917 | -467,898 | -422,709 | -392,601 | -353,520 |
| Other shareholders' equity | -206 | -130 | 4 | 27 | 40 |
| TOTAL | $47,724 | $75,635 | $-1,126 | $-454 | $14,806 |
| Total Liabilities And Equity | $122,359 | $136,874 | $48,866 | $57,439 | $82,208 |